STRS Ohio’s Nuvation Bio NUVB Stock Holding History

STRS Ohio’s Portfolio NUVB Stock Details NUVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$7.29K	Hold	1,700	–	–	﹤0.01%	2098
2025 Q4	$15.2K	Hold	1,700	–	–	﹤0.01%	2117
2025 Q3	$6.29K	Hold	1,700	–	–	﹤0.01%	2172
2025 Q2	$3.31K	Hold	1,700	–	–	﹤0.01%	2188
2025 Q1	$2.99K	Sell	1,700 -36,900	-96%	-$84K	﹤0.01%	1906
2024 Q4	$103K	Hold	38,600	–	–	﹤0.01%	1629
2024 Q3	$88.4K	Hold	38,600	–	–	﹤0.01%	1728
2024 Q2	$113K	Buy	38,600 +3,900	+11%	+$11.9K	﹤0.01%	1677
2024 Q1	$126K	Sell	34,700 -2,200	-6%	-$4.22K	﹤0.01%	1646
2023 Q4	$55K	Hold	36,900	–	–	﹤0.01%	1762
2023 Q3	$49K	Hold	36,900	–	–	﹤0.01%	1795
2023 Q2	$66K	Hold	36,900	–	–	﹤0.01%	1776
2023 Q1	$61K	Hold	36,900	–	–	﹤0.01%	1763
2022 Q4	$70K	Hold	36,900	–	–	﹤0.01%	1771
2022 Q3	$82K	Hold	36,900	–	–	﹤0.01%	1772
2022 Q2	$119K	Hold	36,900	–	–	﹤0.01%	1730
2022 Q1	$194K	Hold	36,900	–	–	﹤0.01%	1716
2021 Q4	$313K	Buy	36,900 +21,600	+141%	+$199K	﹤0.01%	1604
2021 Q3	$152K	Buy	15,300 +7,100	+87%	+$64.4K	﹤0.01%	1854
2021 Q2	$76K	Buy	+8,200	New	+$93.5K	﹤0.01%	2034

Other funds holding NUVB

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

OFM

Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

DFO

Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

STRS Ohio's NUVB Position: Q1 2026 in Review

STRS Ohio held its Nuvation Bio (NUVB) position steady in Q1 2026 at 1,700 shares worth $7.29K. The position accounts for ﹤0.01% of the portfolio, ranked #2098.

STRS Ohio first reported a position in NUVB in Q2 2021 and has held it in 20 quarters since. The position peaked at $313K in Q4 2021. 231 funds tracked by Wall St. Rank hold NUVB as of Q1 2026.

STRS Ohio held 1,700 shares of Nuvation Bio worth $7.29K as of Q1 2026.
STRS Ohio left its Nuvation Bio share count unchanged in Q1 2026.
Nuvation Bio made up ﹤0.01% of STRS Ohio's portfolio in Q1 2026, its #2098 holding.
STRS Ohio first reported a position in Nuvation Bio in Q2 2021 and has held it in 20 quarters since.
STRS Ohio's Nuvation Bio position peaked at $313K in Q4 2021.
231 funds tracked by Wall St. Rank held Nuvation Bio as of Q1 2026.

Based on STRS Ohio's 13F filing for Q1 2026, filed 24 Apr 2026.